A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery

We are thrilled to share our latest publication in the journal “ACS Medicinal Chemistry Letters” titled – A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery.

In this study, we highlighted recently published applications of CETSA® and how the data generated can enable efficient decision-making and prioritization throughout the drug discovery and development value chain. Over the years, CETSA® method has guided numerous projects by providing insights about, for example, target engagement, lead generation, target identification, lead optimization, and preclinical profiling.

Follow this link to read the paper.

A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery | ACS Medicinal Chemistry Letters

 

You don’t have access to the article? Fill in the form below and claim your complimentary full text copy!

amclct.2023.14.issue-4.xlargecover-2

Are you sure?

Is you target compound really theraputic?